Sana Biotechnology (SANA) Other financing activities (2020 - 2026)

Sana Biotechnology has reported Other financing activities for 7 years, with the latest figure at $59000.0 in Q1 2026.

• Quarterly Other financing activities fell 94.76% year-over-year to $59000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 77.68% YoY) and the FY2025 annual result came in at $2.7 million, down 75.68% from the prior year.
• Other financing activities eased to $59000.0 in Q1 2026 per SANA's latest filing, from $1.1 million in the prior quarter.
• Over five years, Other financing activities peaked at $4.9 million in Q1 2024 and troughed at $59000.0 in Q1 2026.
• A 5-year average of $1.3 million and a median of $1.1 million in 2025 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2024: Other financing activities sank 99.9% in 2022, then jumped 1988.56% in 2024.
• Over 5 years, Other financing activities stood at $1.2 million in 2022, then soared by 44.17% to $1.7 million in 2023, then slumped by 59.05% to $699000.0 in 2024, then soared by 51.5% to $1.1 million in 2025, then sank by 94.43% to $59000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $59000.0, $1.1 million, and $157000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.